FibroGen Stock Options
| FGEN Stock | USD 1.14 0.01 0.87% |
FibroGen's option chain provides insight into all available option contracts written on FibroGen's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of FibroGen's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given FibroGen option contract.
In The Money vs. Out of Money Option Contracts on FibroGen
Analyzing FibroGen's in-the-money options over time can help investors to take a profitable long position in FibroGen regardless of its overall volatility. This is especially true when FibroGen's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money FibroGen's options could be used as guardians of the underlying stock as they move almost dollar for dollar with FibroGen's stock while costing only a fraction of its price.
FibroGen's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 226.38 with a put-to-call open interest ratio of 1.28 over 22 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on 2024-05-17. The current put volume is at 18, with calls trading at the volume of 318. This yields a 0.06 put-to-call volume ratio. The FibroGen option chain provides detailed quote and price information for the current FibroGen option contracts. It shows all of FibroGen's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
FibroGen option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in FibroGen's lending market. For example, when FibroGen's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on FibroGen, he or she must hedge the risk by shorting FibroGen stock over its option's life.
2024-05-17
The chart above shows FibroGen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. FibroGen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for FibroGen's option, there is no secondary market available for investors to trade.
FibroGen's stock options are financial instruments that give investors the right to buy or sell shares of FibroGen common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell FibroGen stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If FibroGen's stock price goes up or down, the stock options follow.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Please note that buying 'in-the-money' options on FibroGen lessens the impact of time decay, as they carry both intrinsic and time value. So, even if FibroGen's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money FibroGen contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if FibroGen Stock moves the wrong way.
At this time, FibroGen's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 23rd of April 2024, Capital Stock is likely to grow to about 1 M, though Total Stockholder Equity is likely to grow to (194 M). FibroGen In The Money Call Balance
When FibroGen's strike price is surpassing the current stock price, the option contract against FibroGen stock is said to be in the money. When it comes to buying FibroGen's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on FibroGen are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
FibroGen Current Options Market Mood
FibroGen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps FibroGen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of FibroGen's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. FibroGen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current FibroGen's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current FibroGen contract
Base on the Rule 16, the options market is currently suggesting that FibroGen will have an average daily up or down price movement of about 14.15% per day over the life of the 2024-05-17 option contract. With FibroGen trading at USD 1.14, that is roughly USD 0.16. If you think that the market is fully incorporating FibroGen's daily price movement you should consider buying FibroGen options at the current volatility level of 226.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
FibroGen |
Purchasing FibroGen options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" FibroGen calls. Remember, the seller must deliver FibroGen stock to the call owner when a call is exercised.
FibroGen Option Chain
When FibroGen's strike price is surpassing the current stock price, the option contract against FibroGen stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
FibroGen's option chain is a display of a range of information that helps investors for ways to trade options on FibroGen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for FibroGen. It also shows strike prices and maturity days for a FibroGen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $0.5 | 0.9017 | 0.1088 | 60 | 2024-05-17 | 0.55 - 1.05 | 1.7 | In |
Call | 2024-05-17 CALL at $1.0 | 0.7017 | 0.7172 | 228 | 2024-05-17 | 0.2 - 0.4 | 0.26 | In |
Call | 2024-05-17 CALL at $1.5 | 0.4247 | 0.6026 | 32 | 2024-05-17 | 0.1 - 0.25 | 0.15 | Out |
Call | 2024-05-17 CALL at $2.0 | 0.2577 | 0.4795 | 229 | 2024-05-17 | 0.05 - 0.15 | 0.08 | Out |
Call | 2024-05-17 CALL at $2.5 | 0.1708 | 0.3591 | 355 | 2024-05-17 | 0.0 - 0.1 | 0.05 | Out |
Put | 2024-05-17 PUT at $1.0 | -0.3011 | 0.524 | 568 | 2024-05-17 | 0.15 - 0.25 | 0.18 | Out |
Put | 2024-05-17 PUT at $1.5 | -0.7002 | 0.8034 | 268 | 2024-05-17 | 0.25 - 0.6 | 0.45 | In |
Put | 2024-05-17 PUT at $2.0 | -0.6705 | 0.4512 | 36 | 2024-05-17 | 0.8 - 1.05 | 0.98 | In |
Put | 2024-05-17 PUT at $2.5 | -0.7881 | 0.3724 | 270 | 2024-05-17 | 1.35 - 1.5 | 0.9 | In |
Put | 2024-05-17 PUT at $3.0 | -0.6256 | 0.3014 | 0 | 2024-05-17 | 1.4 - 2.7 | 0.0 | In |
Put | 2024-05-17 PUT at $3.5 | -0.6658 | 0.2838 | 0 | 2024-05-17 | 2.35 - 2.7 | 0.0 | In |
Put | 2024-05-17 PUT at $4.0 | -0.6165 | 0.2556 | 0 | 2024-05-17 | 2.75 - 3.4 | 0.0 | In |
Put | 2024-05-17 PUT at $4.5 | -0.5466 | 0.2259 | 0 | 2024-05-17 | 3.3 - 4.0 | 0.0 | In |
Put | 2024-05-17 PUT at $5.0 | -0.5511 | 0.2183 | 0 | 2024-05-17 | 3.8 - 4.5 | 0.0 | In |
Put | 2024-05-17 PUT at $7.5 | -0.5175 | 0.1851 | 0 | 2024-05-17 | 6.3 - 7.1 | 0.0 | In |
FibroGen Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
FibroGen Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
FibroGen Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in FibroGen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
FibroGen Corporate Directors
FibroGen corporate directors refer to members of a FibroGen board of directors. The board of directors generally takes responsibility for the FibroGen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of FibroGen's board members must vote for the resolution. The FibroGen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Thomas Kearns | Independent Director | Profile | |
| Jorma Routti | Independent Director | Profile | |
| Jeffrey Edwards | Director | Profile | |
| James Schoeneck | Independent Director | Profile |
Already Invested in FibroGen?
The danger of trading FibroGen is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of FibroGen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than FibroGen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile FibroGen is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether FibroGen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of FibroGen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fibrogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fibrogen Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.